Michael John Sumner - Jun 30, 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Medical Officer
Signature: /s/ Michael John Sumner
Stock symbol: INO
Transactions as of: Jun 30, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/3/2023, 05:12 PM
Previous filing: May 17, 2023
Next filing: Feb 28, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+35K			35K	Jun 30, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-35K	-33.33%	$0.00	70K	Jun 30, 2023	Common Stock	35K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.